"Alerted.org

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.

Job Description

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers.

We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come.

**Director, Global Value** Access Strategy (GVAS). This role reports to the Senior Director, GVA lead for Anito-cel in Multiple Myeloma, and will be located at Kite’s US headquarters in Santa Monica, CA.

In this position, you will be a critical GVA partner for two key launches of our potentially best in class CAR T in RR-MM

- **Execute the 4L+ iMMagine-1 Global Launch** , where you will be developing the global market access strategy to support the ex-US launch together with the key commercialization functions of Marketing, Medical Affairs, and Technical Operations and regional Access team

- **Prepare the 2L+ iMMagine-3 Global Launch,** where you will partner with regional (US, ACE, ICR) teams to optimize the access and reimbursement strategies for anito-cel in 2L RR-MM. Working closely with HEOR/RWE to ensure the production of compelling Payer Value Evidence tools to ensure rapid access.

**Key Responsibilities** :

+ Key Market Access representative and lead in the Global Brand Team and Join-GBT for anito-cel

+ In the Value Access Sub-Team, you will be partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure seamless execution of the Access Strategy.

+ Analyze future market access trends and competitor entry and advise the GBT/PT on access-relevant endpoints, study designs, and magnitude of effect to be targeted to achieve reimbursement. The focus will be on Kite’s major markets of US, Australia, Canada, EU-5 (ACE-7), and Japan. You will inform development plans to ensure that Kite pursues evidence generation plans that are meeting payer needs and ultimately, Kite’s commercial ambitions

+ Provide input into clinical development programs to capture value, align to what is meaningful to patients, support a differentiated target product profile (TPP), and ensure the right evidence is collected to support future reimbursement and pricing negotiations

+ Accountable for the market access and payer perspective to be reflected in cross functional strategies (product development, medical affairs, regulatory affairs, commercial)

+ Partner with Health Economics Outcomes Research (HEOR), Real-World Evidence (RWE), and Global Marketing to ensure meaningful target product profiles are developed and evidence plans are optimized to support reimbursement

+ Identify global HEOR evidence requirements and gaps; coordinate with HEOR to develop studies, models, and resources to support value demonstration and product differentiation for assigned indication(s)

Basic Qualifications

+ 12+ Years with BS/BAOR

+ 10+ Years with MS/MA or MBA

Preferred Experience

+ Previous experience supporting product launches, ideally in oncology

+ Demonstrated experience in healthcare environment, preferably pharmaceutical industry, or related consulting services

+ Extensive understanding of the global hematology / multiple myeloma market access landscape, the business of cell therapy, and healthcare system dynamics

+ Detailed knowledge of payer systems, pricing and reimbursement mechanisms, decision-makers, and payer stakeholder behavior for relevant markets (US, EU5, Japan)

+ Knowledge of HTA assessments including value frameworks utilized, methodologies, trends, and drivers in relevant markets

+ Ability to guide the development plan and lead inputs based on payer requirements / market access trends

+ Excellent communication skills and experience in presenting at senior committees

+ Ability to collaborate successfully and cooperatively with colleagues across multiple cultures and time-zones

+ Demonstrated leadership in cross-functional teams

People Leader Accountabilities:

•Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the

way they manage their teams.

•Develop Talent - understand the skills, experience, aspirations and potential of their employees and coach them on current

performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and

realize their purpose.

•Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding

them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.

The salary range for this position is: $205,615.00 - $266,090.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit:

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com . Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma .

For jobs in the United States:

Kite Pharma is committed to providing equal employment opportunities to all employees and applicants for employment, and is dedicated to fostering an inclusive work environment comprised of diverse perspectives, backgrounds, and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, sex, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact [email protected] for assistance.

For more information about equal employment opportunity protections, please view the 'Know Your Rights' (https://www.eeoc.gov/employers/eeo-law-poster) poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT (http://www.dol.gov/whd/regs/compliance/posters/eppac.pdf)

YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Kite Pharma will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Kite Pharma provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Kite Pharma Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.

Change The World With Us

Everyone at Kite is grounded by one common goal – curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work.

We are creating Kite together, with the recognition that the best teams are built by the best people. We maintain an attitude of curiosity, and creativity with each challenge as we develop a new market for cancer therapies. We appreciate and respect one another, and most importantly, we don’t take success for granted.

While we’ve come a long way to make what others viewed as impossible, possible, we know one thing is certain. Today is just the beginning.